Monoclonal Antibodies for the Detection of Thrombosis

  • P. J. Gaffney
  • P. S. Gascoine
  • L. J. Creighton
  • P. M. Tymkewycz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 281)


The early detection of vascular occlusions or the propensity to such occlusions is of primary importance in human medicine. Since fibrin is an important structural component in both venous and arterial thrombi (1) the detection of fibrin and its fragments in vivo or in the circulating blood has underpinned a number of strategies for the early diagnosis of thrombosis.


Fibrin Degradation Product Gamma Chain Human Fibrinogen Deep Vein Thrombus Quantitative Enzyme Immunoassay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. J. Gaffney, M. Brasher, K. Lord, C. J. L. Strachan, A. R. Wilkinson, V. V. Kakkar, and M. F. Scully, Fibrin subunits in venous and arterial thromboembolism. Cardiovasc. Res., 10:421 (1976).PubMedCrossRefGoogle Scholar
  2. 2.
    D. Collen, On the regulation and control of fibrinolysis. Thromb. Haemost., 43:77 (1980).PubMedGoogle Scholar
  3. 3.
    P. J. Gaffney, Fibrinolysis, in: “Thrombosis and Haemostasis.” A. L. Bloom, D. P. Thomas (eds) Churchill Livingstone, Edinburgh p. 223 (1987).Google Scholar
  4. 4.
    E. F. Plow and T. S. Edgington, Surface markers of fibrinogen and its physiological derivatives revealed by antibody probes, Sem. Thromb. Haemost., 8:36 (1982).CrossRefGoogle Scholar
  5. 5.
    B. Kudryk, Z. D Grossman, J. G. McAfee and S. F. Rosebrough, Monoclonal antibodies as probes for fibrin(ogen) proteolysis, in: “Monoclonal Antibodies in Immunoscintigraphy.” J.-F. Chatal (Ed) CRC Press, Boca Raton, FL., Ch. 19, 365 (1989).Google Scholar
  6. 6.
    P. J. Gaffney, The biochemistry of fibrinogen and fibrin degradation products, in: “The Biochemistry, Physiology and Pathology of Haemostasis. D. Ogston and B. Bennet (Eds) John Wiley, New York P. 105 (1977).Google Scholar
  7. 7.
    C. S. Francis and V. J. Marder, A molecular model of plasmic degradation of cross-linked fibrin. Sem. Thromb. Haemost., 8:25 (1981).CrossRefGoogle Scholar
  8. 8.
    C. G. Curtis, Plasma factor XIII, in: “Thrombosis and Haemostasis.” A. L. Bloom, D. P. Thomas (Eds) Churchill Livingstone, Edinburgh pp. 216 (1987).Google Scholar
  9. 9.
    P. J. Gaffney and F. D. P., Lancet 2:1422 (1972).PubMedCrossRefGoogle Scholar
  10. 10.
    D. B. Rylatt, A. S. Blake, L. E. Cottis, D. A. Massingham, W. A. Fletcher, P. P. Masci, A. N. Whitaker, M. Elms, I. Bunce, A. J. Webber, D. Wyatt and P. G. Bundesen, An immunoassay for human D-dimer using monoclonal antibodies, Thromb. Res., 31:767 (1983).PubMedCrossRefGoogle Scholar
  11. 11.
    A. N. Whitaker, M. Elms, P. P. Masci, P. G. Bundesen, D. B. Rylatt, A. J. Webber and I. Bunce, Measurement of crosslinked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies, J. Clin. Path.,37:882 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    M. Elms. I. H. Bunce, P. G. Bundesen, D. B. Rylatt, A. J. Webber, P. P. Masci and A. N. Whitaker, Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies, Thromb. Haemost.,50:591 (1983).PubMedGoogle Scholar
  13. 13.
    P. J. Gaffney, L. J. Creighton, M. J. Perry, M. Callus, R. Thorpe and M. Spitz, Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP) I: Characterisation and preliminary evaluation in plasma, Br. J. Haematol., 68:83 (1988).PubMedCrossRefGoogle Scholar
  14. 14.
    P. J. Gaffney, L. J. Creighton, M. Callus and R. Thorpe, Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP) II: Evaluation in a variety of clinical conditions, Br. J. Haematol., 68:91 (1988).PubMedCrossRefGoogle Scholar
  15. 15.
    S. Rogers, P. M. Sweetman, M. J. Perry and P. J. Gaffney, Plasma levels of fibrin fragments in men with myocardial infarction, Thromb. Res., 43:389 (1985).CrossRefGoogle Scholar
  16. 16.
    R. Thorpe, M. J. Perry, M. Callus, P. J. Gaffney and M. Spitz, Single shot intrasplenic immunisation: an advantageous procedure for production of monoclonal antibodies to human fibrin fragments, “Hybridoma” 3:381 (1984).PubMedCrossRefGoogle Scholar
  17. 17.
    P. J. Gaffney, L. J. Creighton, A. Curry, B. Mahon and R. Thorpe, Monoclonal antibodies to crosslinked fibrin degradation products: comparison of specificities of IgM and IgG subclasses, in:“Fibrinogen: Biochemistry, Physiology and Clinical Relevance.” C. D. O. Lowe, J. T. Douglas, C. D. Forbes, A. Henschen (Eds) Elsevier, Amsterdam pp. 193 (1987).Google Scholar
  18. 18.
    P. J. Gaffney, L. J. Creighton, R. Harris and M. J. Perry, in: “Monoclonal antibodies (mabs) to crosslinked fibrin fragments; their characterisation and potential clinical use, Fibrinogen and its Derivatives.’ G. Muller-Berghaus, U. Scheefers-Borchel,E. Selmayr, A. Henschen (Eds) Elsevier, Amsterdam pp. 273 (1986).Google Scholar
  19. 19.
    J. Koopman, F. Haverkate, P. W. Koppert, W. Nieuwenhuizen, E. J. P. Brommer and W. G. L. van der Werf, New immunoassay of fibrin(-ogen) degradation products in plasma using a monoclonal antibody, J. Lab. Clin. Med., 109:75 (1987).PubMedGoogle Scholar
  20. 20.
    P. W. Koppert, W. Kuipers, B. Hoegee-de Nobel, E. J. P. Brommer, J. Koopman and W. Nieuwenhuizen, A quantitative enzyme immunoassay (EIA) for primary fibrinogenolysis products in plasma, Thromb. Haemost., 57:25 (1987).PubMedGoogle Scholar
  21. 21.
    V. B. Bosnjakovic, B. D. Jankovic, J. Horvat and J. Cvoric, Radiolabelled anti-human fibrin antibody: a new thrombus-detecting agent, Lancet, 1:452 (1977).PubMedCrossRefGoogle Scholar
  22. 22.
    E. Plow and T. S. Edgington, Discriminatory neoantigenic differences between fibrinogen and fibrin derivatives, Proc. Natl. Acad. Sci. USA, 70:1169 (1973).PubMedCrossRefGoogle Scholar
  23. 23.
    E. Plow and T. S. Edgington, Surface markers of fibrinogen and its physiological derivatives revealed by antibody probes, Sem. Thromb. Haemost., 8:35 (1982).CrossRefGoogle Scholar
  24. 24.
    J. H. Sobel, S. Birken, P. Ehrlich, R. Friedman, Z. Moustafa and R. E. Canfield, Characterisation of a crosslink-containing fragment derived from the x-polymer of human fibrin and its application in immunologic studies using monoclonal antibodies, Thromb. Haemost., 46:240 (abstract) (1981).Google Scholar
  25. 25.
    B. Lahiri, J. A. Koehn, R. E. Canfield, S. Birken and J. Lewis, Development of an immunoassay for the COOH-terminal region of the gamma chains of human fibrin, Thromb. Res.,23:103 (1981).PubMedCrossRefGoogle Scholar
  26. 26.
    P. J. Gaffney and P. Dobos, A structural aspect of human fibrinogen suggested by its plasmin degradation, FEBS Lett,15:13 (1971).Google Scholar
  27. 27.
    S. F. Rosebrough, B. Kudryk, Z. D. Grossman, J. G. McAfee, G. Subramanian, C. A. Ritter-Hrncirik, L. S. Witanowski and G. Tillapaugh-Fay, Radioimmunoimaging of venous thrombi using iodine-131 monoclonal antibody, Radiology,156:515 (1985).PubMedGoogle Scholar
  28. 28.
    L. C. Knight, Imaging thrombi with radiolabelled anti-fibrin monoclonal antibodies, Nucl. Med. Comm., 9:823 (1989).CrossRefGoogle Scholar
  29. 29.
    P. Broadhurst, R. Wilkins and A. Lahiri, Fibrin monoclonal antibodies in diagnosis of deep venous thrombosis, Lancet, 3:272 (1989).CrossRefGoogle Scholar
  30. 30.
    K. Y. Hui, E. Haber and G. R. Matsuda, Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen, Science, 222:1129 (1983).PubMedCrossRefGoogle Scholar
  31. 31.
    R. I. J. Feitsma, D. Blok, M. N. J. M. Wasser, W. Nieuwenhuizen and E. K. J. Pauwels, A new method for 99Tcm — labelling of proteins with an application to clot detection with an antifibrin monoclonal antibody, Nucl. Med. Comm., 8:771 (1987).CrossRefGoogle Scholar
  32. 32.
    P. M. Tymkewycz, L. J. Creighton, P. S. Gascoine, G. D. Zanelli, P. M. Webbon and P. J. Gaffney, Imaging of human thrombi in the rabbit jugular vein: comparison of two fibrin specific monoclonal antibodies, Thromb. Res., 54:411–421 (1989).PubMedCrossRefGoogle Scholar
  33. 33.
    P. M. Tymkewycz, P. S. Gascoine and P. J. Gaffney, A Monoclonal antibody (mab) to an A-alpha chain epitope which is exposed only on the surface of fibrin, Thromb. Haemost. , 62:478 (1989).Google Scholar
  34. 34.
    R. K. Ito, G. L. Davis, E. J. Yunis, A Houranieh and B. E. Statland, Immunofibrinolysis: human fibrin-specific monoclonal antibodies as carriers for fibrinolytic agents, Thromb. Haemost., 54:276 (1985).Google Scholar
  35. 35.
    C. Bode, G. R. Matsueda, K. Y. Hui and E. Haber, Antibody-directed urokinase: a specific fibrinolytic agent, Science 229:765 (1985).PubMedCrossRefGoogle Scholar
  36. 36.
    D. Collen, M. Dewerchin, J. M. Stassen, L. Kieckens and H. R. Lijnen, Thrombolytic and pharmacokinetic properties of conjugates of urokinase-type plasminogen activated with a monoclonal antibody specific for crosslinked fibrin, Fibrinolysis,3:197 (1989).Google Scholar
  37. 37.
    M. Dewerchin, H. R. Lijnen and D. Collen. Characterisation of a chemical conjugate between a low molecular weight form of recombinant single chain urokinase-type plasminogen activator (comprising Leu144 through Leu411) and F(ab’)2 — fragments of a fibrin D dimer-specific monoclonal antibody. Fibrinolysis, 4:11 (1990).Google Scholar
  38. 38.
    M. Dewerchin, H. R. Lijnen, B. van Hoef, F. De Cock and D. Collen, Characterisation of conjugates of thrombin-treated single chain urokinase type plasminogen activator with a monoclonal antibody specific for crosslinked fibrin, Fibrinolysis, 4:19 (1990).Google Scholar
  39. 39.
    J. M. Schnee, M. S. Runge, G. R. Matsueda, N. W. Hudson, J. G. Seidman, E. Haber and T. Quertermous, Construction and expression of a recombinant antibody-targeted plasminogen activator. Proc. Natl. Acad. Sci. USA,84:6904 (1987).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • P. J. Gaffney
    • 1
  • P. S. Gascoine
    • 1
  • L. J. Creighton
    • 1
  • P. M. Tymkewycz
    • 1
  1. 1.National Institute for Biological Standards and Control Blanche LaneHertfordshireUK

Personalised recommendations